CARGO Therapeutics, Inc.
CRGXDelisted Aug 19, 2025- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001966494
CARGO Therapeutics, Inc. was delisted on Aug 19, 2025; its insiders filed their last Form 4 on Aug 19, 2025; 117 institutions reported holding it in 13F filings for Q2 2025, worth $196.6M in total; no superinvestor held it.
13F holders, Q3 2025
Institutional positions in CARGO Therapeutics, Inc. as of Sep 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
CRGX is no longer listed, and 13F filings after Q2 2025 list far fewer holders. See Q2 2025
- Institutional holders
- 1
- −116 vs. Q2 2025
- Shares held
- 161
- −47.7M (−100.0%) vs. Q2 2025
- Total value
- $720
- −$196.6M (−100.0%) vs. Q2 2025
- New holders
- 0
- 1 more added
- Sold out
- 116
- 0 more reduced
Compare with Q2 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CRGX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 1 | $720 |
| Q2 2025 | 117 | $196.6M |
| Q1 2025 | 114 | $188.4M |
| Q4 2024 | 100 | $781.3M |
| Q3 2024 | 79 | $865.1M |
| Q2 2024 | 73 | $716.3M |
| Q1 2024 | 65 | $811.9M |
| Q4 2023 | 45 | $809.1M |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 0 | $0 |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q3 2025
Shares, value and share of portfolio for each institution holding CARGO Therapeutics, Inc.; share changes are against Q2 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| EverSource Wealth Advisors, LLC | 0 | $0 | 0.00% | −862−100.0% | Sold out |
| Skopos Labs, Inc. | 0 | $0 | 0.00% | −420−100.0% | Sold out |
| Atwood & Palmer Inc | 0 | $0 | 0.00% | −350−100.0% | Sold out |
| GAMMA Investing LLC | 0 | $0 | 0.00% | −292−100.0% | Sold out |
| Farther Finance Advisors, LLC | 0 | $0 | 0.00% | −281−100.0% | Sold out |
| Nisa Investment Advisors, LLC | 0 | $0 | 0.00% | −268−100.0% | Sold out |
| Daiwa Securities Group Inc. | 0 | $0 | 0.00% | −152−100.0% | Sold out |
| Larson Financial Group LLC | 0 | $0 | 0.00% | −205−100.0% | Sold out |
| Cornerstone Planning Group LLC | 0 | $0 | 0.00% | −164−100.0% | Sold out |
| Allworth Financial LP | 0 | $0 | 0.00% | −165−100.0% | Sold out |
| Versant Capital Management, Inc | 0 | $0 | 0.00% | −63−100.0% | Sold out |
| Advisor Group Holdings, Inc. | 0 | $0 | 0.00% | −53−100.0% | Sold out |
| Rothschild Investment LLC | 0 | $0 | 0.00% | −30−100.0% | Sold out |
| Essential Partners LLC | 0 | $0 | 0.00% | −14−100.0% | Sold out |
| True Wealth Design, LLC | 0 | $0 | 0.00% | −12−100.0% | Sold out |
| SBI Securities Co., Ltd. | 0 | $0 | 0.00% | −5−100.0% | Sold out |
| Capital Advisors, Ltd. LLC | 0 | $0 | 0.00% | −103−100.0% | Sold out |